Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

标题
Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 13, Issue 6, Pages 1537-1548
出版商
American Association for Cancer Research (AACR)
发表日期
2014-04-09
DOI
10.1158/1535-7163.mct-13-0926

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started